This Week in Cannabis: Why All the Excitement Around Medical Marijuana?

Henry Truc  |

In our second week of The Future of Cannabis program, we took a deep dive into arguably the most compelling area of this growth industry to date. The biotech and healthcare segment of the rapidly emerging cannabis market largely revolves around the effects of specific components of cannabis–known as cannabinoids–and their effects on the human body, or more specifically the endocannabinoid system (ECS).

Over the course of this past week, Equities.com and Viridian Capital Advisors detailed the history, progress and players of the cannabis biotech and pharma industry. We spoke with leading researchers and company executives looking to make a difference and pioneering a new area of innovation to help patients. We’ve also laid out the economic and investment potential as the market continues to mature. As we begin to really dive deeper into the specific opportunities of the wider legalization of cannabis, this is definitely a subject investors need to educate themselves on.

To learn more about The Future of Cannabis program, we encourage you to read What is The Future of Cannabis?

Here’s a recap of everything we published in our Week Two focus on the Biotech and Pharma Cannabis Market.

Why the Biotech Market is Looking to Cannabis for the Future: In our first sector deep dive feature, we look at the history and research of the endocannabinoid system and why more and more of the medical and scientific community believe that cannabis holds a lot of promise as a better alternative to the treatments patients have available to them today. More importantly, learn more about the innovative companies leading in this space.

Expert Interviews: We wanted to serve as a platform for leading voices in the cannabis market to provide their perspectives and to encourage dialogue about the industry. Here’s who we heard from this week

Video Exclusives:

Sector Research: Did you know that the cannabis biotech/pharma market could reach over $20 billion within the next five years? In this report, Viridian Capital Advisors lays out their research on the trends and opportunities to play this potential boom.

Our week three coverage of the cannabis market is sure to be a doozy. While the biotech/pharma group is incredibly compelling in its own right, we’re now getting into radically game-changing trends that could potentially affect the everyday lives of the population in North America, and eventually around the world. The legalization of marijuana for recreational use is expanding at an increasingly rapid pace on state-by-state basis. This is creating enormous opportunities for young businesses to become industry powerhouses of the future with a variety of novel approaches. Be sure to come back next week as we dive in.

You can read more from our special program The Future of Cannabis here. To find out why Equities.com and Viridian Capital Advisors launched this program, be sure to read What is The Future of Cannabis? This program was made possible by the support of our sponsors.Click here for a full list of our sponsors.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Radient Technologies Inc.

Radient Technologies Inc is engaged in research, development and commercialization of environmentally responsible technology for the extraction, isolation and purification of soluble products from a wide range of materials using…